Cellectar Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLRB and other ETFs, options, and stocks.About CLRB
Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination.
CEOJames V. Caruso
CEOJames V. Caruso
Employees11
Employees11
HeadquartersFlorham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded1996
Founded1996
Employees11
Employees11
CLRB Key Statistics
Market cap15.39M
Market cap15.39M
Price-Earnings ratio-0.34
Price-Earnings ratio-0.34
Dividend yield—
Dividend yield—
Average volume203.14K
Average volume203.14K
High today$3.69
High today$3.69
Low today$3.53
Low today$3.53
Open price$3.65
Open price$3.65
Volume35.95K
Volume35.95K
52 Week high$20.59
52 Week high$20.59
52 Week low$2.45
52 Week low$2.45
Stock Snapshot
As of today, Cellectar Biosciences(CLRB) shares are valued at $3.59. The company's market cap stands at 15.39M, with a P/E ratio of -0.34.
During the trading session on 2026-01-17, Cellectar Biosciences(CLRB) shares reached a daily high of $3.69 and a low of $3.53. At a current price of $3.59, the stock is +1.7% higher than the low and still -2.7% under the high.
Trading volume for Cellectar Biosciences(CLRB) stock has reached 35.95K, versus its average volume of 203.14K.
The stock's 52-week range extends from a low of $2.45 to a high of $20.59.
The stock's 52-week range extends from a low of $2.45 to a high of $20.59.
People also own
Based on the portfolios of people who own CLRB. This list is generated using Robinhood data, and it’s not a recommendation.